Searched for
SEROPOSITIVITY RATE
Amid Omicron scare, high 'seropositivity' rate should help India, says expertObserving that data on the new SARS-CoV2 variant, Omicron, is still emerging, an expert has said the very high rate of'seropositivity' shou...- COVID-19: Delhi records 16 new cases, 1 deathThe national capital reported 16 new cases of COVID-19 and one death in a day while the positivity rate stood at 0.04 per cent, according t...
- Delhi logs 34 COVID-19 cases, zero death in a dayAccording to the health bulletin, authorities conducted 48,831 tests, including 36,940 RT-PCR ones, the previous day. There are 309 active ...
- Sixth sero survey shows Delhi had seropositivity rate of 97%: Jain"Women had a higher seropositivity rate than men. Those aged below 18 had a seropositivity rate of 88 per cent, while those aged above 18 h...
- Delhi's sixth sero survey: More than 90 per cent have antibodies"We have found Covid antibodies in more than 90 per cent of the samples collected during the sixth round of the survey," an official source...
- Unscientific to extrapolate mortality count from Sero survey, says VK Paul“Sero surveys are carried out for the specific purpose of enunciating how many people have antibodies and previous exposure to Covid-19. Ex...
- Majority of Mumbai children have antibodies: Sero surveyA paediatric serosurvey conducted by the Mumbai Municipal Corporation (BMC) has shown that 51.18 per cent of children between 1 and 18 year...
- Third wave may not have bigger impact on children: AIIMS-WHO studyConcerns have been raised in India over the probable third wave where children and young age groups were thought to get affected the most. ...
- Government begins tracking data to understand vaccine effectiveness“The system will evaluate the impact of the vaccine. Data harmonisation has started. In the next few weeks we will know the real-world effe...
- Covishield produces more antibodies than Covaxin, finds studyCovishield, from the Oxford-AstraZeneca stable, is manufactured by the Serum Institute of India in Pune. Covaxin is the indigenously manufa...
- Two doses of Covishield, Covaxin produce high levels of immunity, shows studyOxford-AstraZeneca vaccine Covishield is being produced by Serum Institute of India (SII), while Covaxin is manufactured by Bharat Biotech.
- Delta variant counted for 60% of Delhi's COVID-19 cases in April, says studyThe Delta variant, B.1.617.2, is 50 per cent more transmissible than the Alpha variant, B1.117, first discovered in the UK, say researchers...
- Past COVID-19 infection does not fully protect young people against reinfection: LancetIn the study, conducted between May and November 2020, around 10 per cent or 19 out of 189 participants who were previously infected with S...
- Nat’l study: 45% of those tested in December had antibody. It was 18% in JulyThe findings broadly align with sero-surveys in Delhi and Mumbai, said Sandeep Juneja, a senior professor at the Tata Institute of Fundamen...
- High prevalence rates suggest Covid variants driving current surge: StudyThe high prevalence rates suggest variants are driving the current surge since widespread infection is usually thought to bring herd immuni...
- COVID-19 recovered people showing faster antibody response to Covishield vaccine: StudyThe study on the immune response to Covishield was carried out by researchers from New Delhi's CSIR-Institute of Genomics and Integrative B...
- Overall COVID-19 seropositivity among healthcare workers over 25 per cent: Ashwini ChoubeyResponding to a question on how many healthcare workers have contracted COVID-19 virus till date, Choubey said health being a state subject...
- Herd immunity inference from Delhi's sero survey to be taken with pinch of salt, say scientistsOn Tuesday, the Delhi government announced the results of the fifth sero survey, with a sample of 28,000 across 11 districts in Delhi. The ...
- Seropositivity for COVID-19 found to be lesser in smokers, vegetarians: CSIR surveyThe study which was piloted by CSIR-Institute of Genomics and Integrative Biology (IGIB), Delhi said of the 10,427 individuals, 1,058 (10.1...
- Antibodies seen among 11.8% in Aurangabad district; 4,327 samples were studiedAccording to the report, seroprevalence of SARS-CoV-2 was 11.81%. The highest seroprevalence of 17.42% was seen in the 41-50 years age grou...
Load More
